English

NUTRACEUTICAL INTERNATIONAL CORP

EDGAR

Filing (4) · filed 2017-08-24

128 filing records in this dataset, filed from 1998-03-30 to 2017-08-24. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

65 million USD

2017 Q3 · USD

Exact inputs and evidence

Revenue: 64993000 USD Source

Operating margin

6.49%

2017 Q3 · %

Exact inputs and evidence

Operating Income: 4219000 USD Source
Revenue: 64993000 USD Source

Operating cash flow

5.09 million USD

2017 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 16874000 USD Source
Operating Cash Flow: 11782000 USD Source

Free cash flow

2.89 million USD

2017 Q3 · USD

Exact inputs and evidence

Operating Cash Flow: 16874000 USD Source
Operating Cash Flow: 11782000 USD Source
Capital Expenditure: 6475000 USD Source
Capital Expenditure: 4276000 USD Source

Cash and cash equivalents: 4.18 million USD 2017-06-30 Source
Exact value

4183000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 9.2 million shares 2016-09-30 Source
Exact value

9203790 shares

Reported share-count change

-2.99% · -284 thousand shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

9487874 shares · 2015-09-30· Source
9203790 shares · 2016-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

15.7 million USD

2010-10-01 – 2011-09-30

Exact inputs and evidence

Net income: 3947000 USD · 2010-10-01 – 2010-12-31 Source
Net income: 4552000 USD · 2011-01-01 – 2011-03-31 Source
Net income: 3945000 USD · 2011-04-01 – 2011-06-30 Source
Net income: 15718000 USD · 2010-10-01 – 2011-09-30 Source
Net income: 12444000 USD · 2010-10-01 – 2011-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2017-08-24.

Financial data available through: 2016-09-30.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2016-09-30
Operating income: 11 of 11 periods available· newest 2016-09-30
Net income: 6 of 11 periods available· newest 2011-09-30
Operating cash flow: 11 of 11 periods available· newest 2016-09-30
Capital expenditure: 11 of 11 periods available· newest 2016-09-30
Total assets: 10 of 11 periods available· newest 2016-09-30
Total liabilities: 10 of 11 periods available· newest 2016-09-30
Current assets: 10 of 11 periods available· newest 2016-09-30
Current liabilities: 10 of 11 periods available· newest 2016-09-30
Cash and cash equivalents: 11 of 11 periods available· newest 2016-09-30
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2016-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+7.6%

Prior period

USD 216.48 million

2014-10-01 – 2015-09-30
Current period

USD 232.99 million

2015-10-01 – 2016-09-30

Exact inputs and evidence

232988000 − 216479000 = 16509000 USD

216479000 USD · 2014-10-01 – 2015-09-30
Inspect prior input Prior source
232988000 USD · 2015-10-01 – 2016-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · NUTRACEUTICAL INTERNATIONAL CORP · 2016-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Year-over-year change in Revenue: 16509000 USD Concept: fundies:Revenue Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 232988000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#197924 Filing: 000105000716000015 Input fundies:Revenue: 216479000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#196552 Filing: 000105000716000015
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+30.9%

Prior period

USD 25.05 million

2014-10-01 – 2015-09-30
Current period

USD 32.78 million

2015-10-01 – 2016-09-30

Exact inputs and evidence

32777000 − 25046000 = 7731000 USD

25046000 USD · 2014-10-01 – 2015-09-30
Inspect prior input Prior source
32777000 USD · 2015-10-01 – 2016-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2016-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Year-over-year change in Operating cash flow: 7731000 USD Concept: fundies:OperatingCashFlow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: 32777000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#172263 Filing: 000105000716000015 Input fundies:OperatingCashFlow: 25046000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#172012 Filing: 000105000716000015
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+4.6%

Prior period

USD 8.56 million

2014-10-01 – 2015-09-30
Current period

USD 8.95 million

2015-10-01 – 2016-09-30

Exact inputs and evidence

8950000 − 8557000 = 393000 USD

8557000 USD · 2014-10-01 – 2015-09-30
Inspect prior input Prior source
8950000 USD · 2015-10-01 – 2016-09-30
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2016-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Year-over-year change in Capital expenditure: 393000 USD Concept: fundies:CapitalExpenditure Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 8950000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#185134 Filing: 000105000716000015 Input fundies:CapitalExpenditure: 8557000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#184924 Filing: 000105000716000015
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Net income.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2016 2015-10-01 – 2016-09-30

Revenue USD 232.99 million 100% of revenue
Cost of revenue USD 114.94 million 49% of revenue
Operating expenses USD 88.87 million 38% of revenue
Operating income USD 29.18 million 13% of revenue
Tax, interest and other Derived Unavailable An input is unavailable.
Net income Unavailable An input is unavailable.

Cash

Operating cash flow USD 32.78 million 14% of revenue
Capital expenditure USD 8.95 million 3.8% of revenue
Free cash flow Derived USD 23.83 million 10% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2007 86%
2008 88%
2009 Operating loss: operating costs were 110% of revenue.
2010 9.1%85%
2011 87%
2012 Not shown: operating income or net income is not reported.
2013 Not shown: operating income or net income is not reported.
2014 Not shown: operating income or net income is not reported.
2015 Not shown: operating income or net income is not reported.
2016 Not shown: operating income or net income is not reported.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2007 2006-10-01 – 2007-09-30	156548000	134368000 Derived	22180000	9208000 Derived	12972000	13301000 Derived	Source 2006-10-01 – 2007-09-30: 156548000 USD Inspect Revenue Open source 2006-10-01 – 2007-09-30: 22180000 USD Inspect Operating Income Open source 2006-10-01 – 2007-09-30: 12972000 USD Inspect Net Income Open source 2006-10-01 – 2007-09-30: 23768000 USD Inspect Operating Cash Flow Open source 2006-10-01 – 2007-09-30: 10467000 USD Inspect Capital Expenditure Open source
2008 2007-10-01 – 2008-09-30	166885000	146655000 Derived	20230000	8287000 Derived	11943000	2468000 Derived	Source 2007-10-01 – 2008-09-30: 166885000 USD Inspect Revenue Open source 2007-10-01 – 2008-09-30: 20230000 USD Inspect Operating Income Open source 2007-10-01 – 2008-09-30: 11943000 USD Inspect Net Income Open source 2007-10-01 – 2008-09-30: 20337000 USD Inspect Operating Cash Flow Open source 2007-10-01 – 2008-09-30: 17869000 USD Inspect Capital Expenditure Open source
2009 2008-10-01 – 2009-09-30	162346000	178523000 Derived	-16177000	-1541000 Derived	-14636000	18605000 Derived	Source 2008-10-01 – 2009-09-30: 162346000 USD Inspect Revenue Open source 2008-10-01 – 2009-09-30: -16177000 USD Inspect Operating Income Open source 2008-10-01 – 2009-09-30: -14636000 USD Inspect Net Income Open source 2008-10-01 – 2009-09-30: 27781000 USD Inspect Operating Cash Flow Open source 2008-10-01 – 2009-09-30: 9176000 USD Inspect Capital Expenditure Open source
2010 2009-10-01 – 2010-09-30	180052000	153164000 Derived	26888000	10505000 Derived	16383000	6345000 Derived	Source 2009-10-01 – 2010-09-30: 180052000 USD Inspect Revenue Open source 2009-10-01 – 2010-09-30: 26888000 USD Inspect Operating Income Open source 2009-10-01 – 2010-09-30: 16383000 USD Inspect Net Income Open source 2009-10-01 – 2010-09-30: 17870000 USD Inspect Operating Cash Flow Open source 2009-10-01 – 2010-09-30: 11525000 USD Inspect Capital Expenditure Open source
2011 2010-10-01 – 2011-09-30	188070000	162761000 Derived	25309000	9591000 Derived	15718000	13935000 Derived	Source 2010-10-01 – 2011-09-30: 188070000 USD Inspect Revenue Open source 2010-10-01 – 2011-09-30: 25309000 USD Inspect Operating Income Open source 2010-10-01 – 2011-09-30: 15718000 USD Inspect Net Income Open source 2010-10-01 – 2011-09-30: 26340000 USD Inspect Operating Cash Flow Open source 2010-10-01 – 2011-09-30: 12405000 USD Inspect Capital Expenditure Open source
2012 2011-10-01 – 2012-09-30	200367000	174695000 Derived	25672000	Unavailable	Unavailable	17209000 Derived	Source 2011-10-01 – 2012-09-30: 200367000 USD Inspect Revenue Open source 2011-10-01 – 2012-09-30: 25672000 USD Inspect Operating Income Open source 2011-10-01 – 2012-09-30: 27162000 USD Inspect Operating Cash Flow Open source 2011-10-01 – 2012-09-30: 9953000 USD Inspect Capital Expenditure Open source
2013 2012-10-01 – 2013-09-30	208397000	180264000 Derived	28133000	Unavailable	Unavailable	18423000 Derived	Source 2012-10-01 – 2013-09-30: 208397000 USD Inspect Revenue Open source 2012-10-01 – 2013-09-30: 28133000 USD Inspect Operating Income Open source 2012-10-01 – 2013-09-30: 26770000 USD Inspect Operating Cash Flow Open source 2012-10-01 – 2013-09-30: 8347000 USD Inspect Capital Expenditure Open source
2014 2013-10-01 – 2014-09-30	214474000	187977000 Derived	26497000	Unavailable	Unavailable	8740000 Derived	Source 2013-10-01 – 2014-09-30: 214474000 USD Inspect Revenue Open source 2013-10-01 – 2014-09-30: 26497000 USD Inspect Operating Income Open source 2013-10-01 – 2014-09-30: 20038000 USD Inspect Operating Cash Flow Open source 2013-10-01 – 2014-09-30: 11298000 USD Inspect Capital Expenditure Open source
2015 2014-10-01 – 2015-09-30	216479000	192190000 Derived	24289000	Unavailable	Unavailable	16489000 Derived	Source 2014-10-01 – 2015-09-30: 216479000 USD Inspect Revenue Open source 2014-10-01 – 2015-09-30: 24289000 USD Inspect Operating Income Open source 2014-10-01 – 2015-09-30: 25046000 USD Inspect Operating Cash Flow Open source 2014-10-01 – 2015-09-30: 8557000 USD Inspect Capital Expenditure Open source
2016 2015-10-01 – 2016-09-30	232988000	203811000 Derived	29177000	Unavailable	Unavailable	23827000 Derived	Source 2015-10-01 – 2016-09-30: 232988000 USD Inspect Revenue Open source 2015-10-01 – 2016-09-30: 29177000 USD Inspect Operating Income Open source 2015-10-01 – 2016-09-30: 32777000 USD Inspect Operating Cash Flow Open source 2015-10-01 – 2016-09-30: 8950000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 233M 2016

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-09-30	Revenue	156548000	Revenue: 156548000 Open source
20082008-09-30	Revenue	166885000	Revenue: 166885000 Open source
20092009-09-30	Revenue	162346000	Revenue: 162346000 Open source
20102010-09-30	Revenue	180052000	Revenue: 180052000 Open source
20112011-09-30	Revenue	188070000	Revenue: 188070000 Open source
20122012-09-30	Revenue	200367000	Revenue: 200367000 Open source
20132013-09-30	Revenue	208397000	Revenue: 208397000 Open source
20142014-09-30	Revenue	214474000	Revenue: 214474000 Open source
20152015-09-30	Revenue	216479000	Revenue: 216479000 Open source
20162016-09-30	Revenue	232988000	Revenue: 232988000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

7.6% 2016

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20072007-09-30	Year over year	4.1%	Revenue: 156548000 Open source Revenue: 150405000 Open source
20082008-09-30	Year over year	6.6%	Revenue: 166885000 Open source Revenue: 156548000 Open source
20092009-09-30	Year over year	-2.7%	Revenue: 162346000 Open source Revenue: 166885000 Open source
20102010-09-30	Year over year	10.9%	Revenue: 180052000 Open source Revenue: 162346000 Open source
20112011-09-30	Year over year	4.5%	Revenue: 188070000 Open source Revenue: 180052000 Open source
20122012-09-30	Year over year	6.5%	Revenue: 200367000 Open source Revenue: 188070000 Open source
20132013-09-30	Year over year	4%	Revenue: 208397000 Open source Revenue: 200367000 Open source
20142014-09-30	Year over year	2.9%	Revenue: 214474000 Open source Revenue: 208397000 Open source
20152015-09-30	Year over year	0.9%	Revenue: 216479000 Open source Revenue: 214474000 Open source
20162016-09-30	Year over year	7.6%	Revenue: 232988000 Open source Revenue: 216479000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 12.5% 2016

Net margin 8.4% 2011

Free cash flow margin 10.2% 2016

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20072007-09-30	Operating margin	14.2%	Operating Income: 22180000 Open source Revenue: 156548000 Open source
20082008-09-30	Operating margin	12.1%	Operating Income: 20230000 Open source Revenue: 166885000 Open source
20092009-09-30	Operating margin	-10%	Operating Income: -16177000 Open source Revenue: 162346000 Open source
20102010-09-30	Operating margin	14.9%	Operating Income: 26888000 Open source Revenue: 180052000 Open source
20112011-09-30	Operating margin	13.5%	Operating Income: 25309000 Open source Revenue: 188070000 Open source
20122012-09-30	Operating margin	12.8%	Operating Income: 25672000 Open source Revenue: 200367000 Open source
20132013-09-30	Operating margin	13.5%	Operating Income: 28133000 Open source Revenue: 208397000 Open source
20142014-09-30	Operating margin	12.4%	Operating Income: 26497000 Open source Revenue: 214474000 Open source
20152015-09-30	Operating margin	11.2%	Operating Income: 24289000 Open source Revenue: 216479000 Open source
20162016-09-30	Operating margin	12.5%	Operating Income: 29177000 Open source Revenue: 232988000 Open source
20072007-09-30	Net margin	8.3%	Net Income: 12972000 Open source Revenue: 156548000 Open source
20082008-09-30	Net margin	7.2%	Net Income: 11943000 Open source Revenue: 166885000 Open source
20092009-09-30	Net margin	-9%	Net Income: -14636000 Open source Revenue: 162346000 Open source
20102010-09-30	Net margin	9.1%	Net Income: 16383000 Open source Revenue: 180052000 Open source
20112011-09-30	Net margin	8.4%	Net Income: 15718000 Open source Revenue: 188070000 Open source
2012-09-30	Net margin	Not reported	Revenue: 200367000 Open source
2013-09-30	Net margin	Not reported	Revenue: 208397000 Open source
2014-09-30	Net margin	Not reported	Revenue: 214474000 Open source
2015-09-30	Net margin	Not reported	Revenue: 216479000 Open source
2016-09-30	Net margin	Not reported	Revenue: 232988000 Open source
20072007-09-30	Free cash flow margin	8.5%	Revenue: 156548000 Open source Operating Cash Flow: 23768000 Open source Capital Expenditure: 10467000 Open source
20082008-09-30	Free cash flow margin	1.5%	Revenue: 166885000 Open source Operating Cash Flow: 20337000 Open source Capital Expenditure: 17869000 Open source
20092009-09-30	Free cash flow margin	11.5%	Revenue: 162346000 Open source Operating Cash Flow: 27781000 Open source Capital Expenditure: 9176000 Open source
20102010-09-30	Free cash flow margin	3.5%	Revenue: 180052000 Open source Operating Cash Flow: 17870000 Open source Capital Expenditure: 11525000 Open source
20112011-09-30	Free cash flow margin	7.4%	Revenue: 188070000 Open source Operating Cash Flow: 26340000 Open source Capital Expenditure: 12405000 Open source
20122012-09-30	Free cash flow margin	8.6%	Revenue: 200367000 Open source Operating Cash Flow: 27162000 Open source Capital Expenditure: 9953000 Open source
20132013-09-30	Free cash flow margin	8.8%	Revenue: 208397000 Open source Operating Cash Flow: 26770000 Open source Capital Expenditure: 8347000 Open source
20142014-09-30	Free cash flow margin	4.1%	Revenue: 214474000 Open source Operating Cash Flow: 20038000 Open source Capital Expenditure: 11298000 Open source
20152015-09-30	Free cash flow margin	7.6%	Revenue: 216479000 Open source Operating Cash Flow: 25046000 Open source Capital Expenditure: 8557000 Open source
20162016-09-30	Free cash flow margin	10.2%	Revenue: 232988000 Open source Operating Cash Flow: 32777000 Open source Capital Expenditure: 8950000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 32.8M 2016

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-09-30	Operating cash flow	23768000	Operating Cash Flow: 23768000 Open source
20082008-09-30	Operating cash flow	20337000	Operating Cash Flow: 20337000 Open source
20092009-09-30	Operating cash flow	27781000	Operating Cash Flow: 27781000 Open source
20102010-09-30	Operating cash flow	17870000	Operating Cash Flow: 17870000 Open source
20112011-09-30	Operating cash flow	26340000	Operating Cash Flow: 26340000 Open source
20122012-09-30	Operating cash flow	27162000	Operating Cash Flow: 27162000 Open source
20132013-09-30	Operating cash flow	26770000	Operating Cash Flow: 26770000 Open source
20142014-09-30	Operating cash flow	20038000	Operating Cash Flow: 20038000 Open source
20152015-09-30	Operating cash flow	25046000	Operating Cash Flow: 25046000 Open source
20162016-09-30	Operating cash flow	32777000	Operating Cash Flow: 32777000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 23.8M 2016

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20072007-09-30	Free cash flow	13301000	Operating Cash Flow: 23768000 Open source Capital Expenditure: 10467000 Open source
20082008-09-30	Free cash flow	2468000	Operating Cash Flow: 20337000 Open source Capital Expenditure: 17869000 Open source
20092009-09-30	Free cash flow	18605000	Operating Cash Flow: 27781000 Open source Capital Expenditure: 9176000 Open source
20102010-09-30	Free cash flow	6345000	Operating Cash Flow: 17870000 Open source Capital Expenditure: 11525000 Open source
20112011-09-30	Free cash flow	13935000	Operating Cash Flow: 26340000 Open source Capital Expenditure: 12405000 Open source
20122012-09-30	Free cash flow	17209000	Operating Cash Flow: 27162000 Open source Capital Expenditure: 9953000 Open source
20132013-09-30	Free cash flow	18423000	Operating Cash Flow: 26770000 Open source Capital Expenditure: 8347000 Open source
20142014-09-30	Free cash flow	8740000	Operating Cash Flow: 20038000 Open source Capital Expenditure: 11298000 Open source
20152015-09-30	Free cash flow	16489000	Operating Cash Flow: 25046000 Open source Capital Expenditure: 8557000 Open source
20162016-09-30	Free cash flow	23827000	Operating Cash Flow: 32777000 Open source Capital Expenditure: 8950000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

27.1% 2016

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20072007-09-30	Liabilities / assets	27.7%	Total Liabilities: 40483000 Open source Total Assets: 146402000 Open source
20082008-09-30	Liabilities / assets	29.8%	Total Liabilities: 48204000 Open source Total Assets: 161664000 Open source
20092009-09-30	Liabilities / assets	28.6%	Total Liabilities: 38322000 Open source Total Assets: 133960000 Open source
20102010-09-30	Liabilities / assets	30.6%	Total Liabilities: 47412000 Open source Total Assets: 154947000 Open source
20112011-09-30	Liabilities / assets	30.3%	Total Liabilities: 51990000 Open source Total Assets: 171665000 Open source
20122012-09-30	Liabilities / assets	29.5%	Total Liabilities: 54862000 Open source Total Assets: 185918000 Open source
20132013-09-30	Liabilities / assets	28.3%	Total Liabilities: 54434000 Open source Total Assets: 192310000 Open source
2014-09-30	Liabilities / assets	Not reported	No source recorded
20152015-09-30	Liabilities / assets	24.6%	Total Liabilities: 52202000 Open source Total Assets: 212449000 Open source
20162016-09-30	Liabilities / assets	27.1%	Total Liabilities: 63865000 Open source Total Assets: 235855000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

4.65× 2016

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20072007-09-30	Current assets / current liabilities	2.54×	Current Assets: 51534000 Open source Current Liabilities: 20275000 Open source
20082008-09-30	Current assets / current liabilities	2.89×	Current Assets: 55577000 Open source Current Liabilities: 19239000 Open source
20092009-09-30	Current assets / current liabilities	2.79×	Current Assets: 50582000 Open source Current Liabilities: 18138000 Open source
20102010-09-30	Current assets / current liabilities	1.28×	Current Assets: 58294000 Open source Current Liabilities: 45673000 Open source
20112011-09-30	Current assets / current liabilities	3.14×	Current Assets: 62069000 Open source Current Liabilities: 19737000 Open source
20122012-09-30	Current assets / current liabilities	3.3×	Current Assets: 68268000 Open source Current Liabilities: 20670000 Open source
20132013-09-30	Current assets / current liabilities	3.44×	Current Assets: 75048000 Open source Current Liabilities: 21796000 Open source
2014-09-30	Current assets / current liabilities	Not reported	No source recorded
20152015-09-30	Current assets / current liabilities	4.2×	Current Assets: 86215000 Open source Current Liabilities: 20528000 Open source
20162016-09-30	Current assets / current liabilities	4.65×	Current Assets: 93866000 Open source Current Liabilities: 20165000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2007 2006-10-01 – 2007-09-30	USD 12.97 million Exact value Exact value: 12972000 USD 2006-10-01 – 2007-09-30: 12972000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRACEUTICAL INTERNATIONAL CORP · 2007-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Net Income: 12972000 USD Concept: fundies:NetIncome Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ANetIncome&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:NetIncome: 12972000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-09-010651.txt#6633 The citation records this snapshot. The page link may show a newer release later.	USD 23.77 million Exact value Exact value: 23768000 USD 2006-10-01 – 2007-09-30: 23768000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2007-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 23768000 USD Concept: fundies:OperatingCashFlow Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 23768000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-09-010651.txt#6873 The citation records this snapshot. The page link may show a newer release later.	USD 10.47 million Exact value Exact value: 10467000 USD 2006-10-01 – 2007-09-30: 10467000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2007-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 10467000 USD Concept: fundies:CapitalExpenditure Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2007-09-30&surface=latest&period_type=duration&start=2006-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 10467000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-09-010651.txt#6927 The citation records this snapshot. The page link may show a newer release later.	USD 13.3 million Calculation and evidence 23768000 − 10467000 USD Exact free cash flow: 13301000 USD 2006-10-01 – 2007-09-30: 23768000 USD · Inspect Operating Cash Flow · Source 2006-10-01 – 2007-09-30: 10467000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2007-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 13301000 USD Concept: free-cash-flow Period: 2006-10-01 to 2007-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 23768000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-09-010651.txt#6873 Input fundies:CapitalExpenditure: 10467000 USD (2006-10-01 to 2007-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-09-010651.txt#6927 The citation records this snapshot. The page link may show a newer release later.
2008 2007-10-01 – 2008-09-30	USD 11.94 million Exact value Exact value: 11943000 USD 2007-10-01 – 2008-09-30: 11943000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRACEUTICAL INTERNATIONAL CORP · 2008-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Net Income: 11943000 USD Concept: fundies:NetIncome Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ANetIncome&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:NetIncome: 11943000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-10-010013.txt#6521 The citation records this snapshot. The page link may show a newer release later.	USD 20.34 million Exact value Exact value: 20337000 USD 2007-10-01 – 2008-09-30: 20337000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2008-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 20337000 USD Concept: fundies:OperatingCashFlow Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 20337000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-10-010013.txt#6761 The citation records this snapshot. The page link may show a newer release later.	USD 17.87 million Exact value Exact value: 17869000 USD 2007-10-01 – 2008-09-30: 17869000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2008-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 17869000 USD Concept: fundies:CapitalExpenditure Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2008-09-30&surface=latest&period_type=duration&start=2007-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 17869000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-10-010013.txt#6815 The citation records this snapshot. The page link may show a newer release later.	USD 2.47 million Calculation and evidence 20337000 − 17869000 USD Exact free cash flow: 2468000 USD 2007-10-01 – 2008-09-30: 20337000 USD · Inspect Operating Cash Flow · Source 2007-10-01 – 2008-09-30: 17869000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2008-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 2468000 USD Concept: free-cash-flow Period: 2007-10-01 to 2008-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 20337000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-10-010013.txt#6761 Input fundies:CapitalExpenditure: 17869000 USD (2007-10-01 to 2008-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-10-010013.txt#6815 The citation records this snapshot. The page link may show a newer release later.
2009 2008-10-01 – 2009-09-30	−USD 14.64 million Exact value Exact value: -14636000 USD 2008-10-01 – 2009-09-30: -14636000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRACEUTICAL INTERNATIONAL CORP · 2009-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Net Income: -14636000 USD Concept: fundies:NetIncome Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ANetIncome&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:NetIncome: -14636000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-11-010134.txt#6600 The citation records this snapshot. The page link may show a newer release later.	USD 27.78 million Exact value Exact value: 27781000 USD 2008-10-01 – 2009-09-30: 27781000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2009-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 27781000 USD Concept: fundies:OperatingCashFlow Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 27781000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746911010134/nutr-20110930.xml#319120 Filing: 000104746911010134 The citation records this snapshot. The page link may show a newer release later.	USD 9.18 million Exact value Exact value: 9176000 USD 2008-10-01 – 2009-09-30: 9176000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2009-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 9176000 USD Concept: fundies:CapitalExpenditure Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2009-09-30&surface=latest&period_type=duration&start=2008-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9176000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746911010134/nutr-20110930.xml#314790 Filing: 000104746911010134 The citation records this snapshot. The page link may show a newer release later.	USD 18.61 million Calculation and evidence 27781000 − 9176000 USD Exact free cash flow: 18605000 USD 2008-10-01 – 2009-09-30: 27781000 USD · Inspect Operating Cash Flow · Source 2008-10-01 – 2009-09-30: 9176000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2009-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 18605000 USD Concept: free-cash-flow Period: 2008-10-01 to 2009-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 27781000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746911010134/nutr-20110930.xml#319120 Filing: 000104746911010134 Input fundies:CapitalExpenditure: 9176000 USD (2008-10-01 to 2009-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746911010134/nutr-20110930.xml#314790 Filing: 000104746911010134 The citation records this snapshot. The page link may show a newer release later.
2010 2009-10-01 – 2010-09-30	USD 16.38 million Exact value Exact value: 16383000 USD 2009-10-01 – 2010-09-30: 16383000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRACEUTICAL INTERNATIONAL CORP · 2010-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Net Income: 16383000 USD Concept: fundies:NetIncome Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ANetIncome&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:NetIncome: 16383000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-11-010134.txt#6600 The citation records this snapshot. The page link may show a newer release later.	USD 17.87 million Exact value Exact value: 17870000 USD 2009-10-01 – 2010-09-30: 17870000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2010-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 17870000 USD Concept: fundies:OperatingCashFlow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 17870000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746912010736/nutr-20120930.xml#99790 Filing: 000104746912010736 The citation records this snapshot. The page link may show a newer release later.	USD 11.53 million Exact value Exact value: 11525000 USD 2009-10-01 – 2010-09-30: 11525000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2010-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 11525000 USD Concept: fundies:CapitalExpenditure Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2010-09-30&surface=latest&period_type=duration&start=2009-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11525000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746912010736/nutr-20120930.xml#100005 Filing: 000104746912010736 The citation records this snapshot. The page link may show a newer release later.	USD 6.35 million Calculation and evidence 17870000 − 11525000 USD Exact free cash flow: 6345000 USD 2009-10-01 – 2010-09-30: 17870000 USD · Inspect Operating Cash Flow · Source 2009-10-01 – 2010-09-30: 11525000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2010-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 6345000 USD Concept: free-cash-flow Period: 2009-10-01 to 2010-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 17870000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746912010736/nutr-20120930.xml#99790 Filing: 000104746912010736 Input fundies:CapitalExpenditure: 11525000 USD (2009-10-01 to 2010-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746912010736/nutr-20120930.xml#100005 Filing: 000104746912010736 The citation records this snapshot. The page link may show a newer release later.
2011 2010-10-01 – 2011-09-30	USD 15.72 million Exact value Exact value: 15718000 USD 2010-10-01 – 2011-09-30: 15718000 USD Inspect Net Income Open source Share or cite Citation for Net Income · NUTRACEUTICAL INTERNATIONAL CORP · 2011-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Net Income: 15718000 USD Concept: fundies:NetIncome Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ANetIncome&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:NetIncome: 15718000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/0001047469-11-010134.txt#6600 The citation records this snapshot. The page link may show a newer release later.	USD 26.34 million Exact value Exact value: 26340000 USD 2010-10-01 – 2011-09-30: 26340000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2011-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 26340000 USD Concept: fundies:OperatingCashFlow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 26340000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#641874 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.	USD 12.41 million Exact value Exact value: 12405000 USD 2010-10-01 – 2011-09-30: 12405000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2011-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 12405000 USD Concept: fundies:CapitalExpenditure Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2011-09-30&surface=latest&period_type=duration&start=2010-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 12405000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#642658 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.	USD 13.94 million Calculation and evidence 26340000 − 12405000 USD Exact free cash flow: 13935000 USD 2010-10-01 – 2011-09-30: 26340000 USD · Inspect Operating Cash Flow · Source 2010-10-01 – 2011-09-30: 12405000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2011-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 13935000 USD Concept: free-cash-flow Period: 2010-10-01 to 2011-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 26340000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#641874 Filing: 000104746913010881 Input fundies:CapitalExpenditure: 12405000 USD (2010-10-01 to 2011-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#642658 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.
2012 2011-10-01 – 2012-09-30	Unavailable Not reported for this period.	USD 27.16 million Exact value Exact value: 27162000 USD 2011-10-01 – 2012-09-30: 27162000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2012-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 27162000 USD Concept: fundies:OperatingCashFlow Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2012-09-30&surface=latest&period_type=duration&start=2011-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 27162000 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#641659 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.	USD 9.95 million Exact value Exact value: 9953000 USD 2011-10-01 – 2012-09-30: 9953000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2012-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 9953000 USD Concept: fundies:CapitalExpenditure Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2012-09-30&surface=latest&period_type=duration&start=2011-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 9953000 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#642089 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.	USD 17.21 million Calculation and evidence 27162000 − 9953000 USD Exact free cash flow: 17209000 USD 2011-10-01 – 2012-09-30: 27162000 USD · Inspect Operating Cash Flow · Source 2011-10-01 – 2012-09-30: 9953000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2012-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 17209000 USD Concept: free-cash-flow Period: 2011-10-01 to 2012-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 27162000 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#641659 Filing: 000104746913010881 Input fundies:CapitalExpenditure: 9953000 USD (2011-10-01 to 2012-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#642089 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.
2013 2012-10-01 – 2013-09-30	Unavailable Not reported for this period.	USD 26.77 million Exact value Exact value: 26770000 USD 2012-10-01 – 2013-09-30: 26770000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2013-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 26770000 USD Concept: fundies:OperatingCashFlow Period: 2012-10-01 to 2013-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2013-09-30&surface=latest&period_type=duration&start=2012-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 26770000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#637284 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.	USD 8.35 million Exact value Exact value: 8347000 USD 2012-10-01 – 2013-09-30: 8347000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2013-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 8347000 USD Concept: fundies:CapitalExpenditure Period: 2012-10-01 to 2013-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2013-09-30&surface=latest&period_type=duration&start=2012-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8347000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#680563 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.	USD 18.42 million Calculation and evidence 26770000 − 8347000 USD Exact free cash flow: 18423000 USD 2012-10-01 – 2013-09-30: 26770000 USD · Inspect Operating Cash Flow · Source 2012-10-01 – 2013-09-30: 8347000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2013-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 18423000 USD Concept: free-cash-flow Period: 2012-10-01 to 2013-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 26770000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#637284 Filing: 000104746913010881 Input fundies:CapitalExpenditure: 8347000 USD (2012-10-01 to 2013-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000104746913010881/nutr-20130930.xml#680563 Filing: 000104746913010881 The citation records this snapshot. The page link may show a newer release later.
2014 2013-10-01 – 2014-09-30	Unavailable Not reported for this period.	USD 20.04 million Exact value Exact value: 20038000 USD 2013-10-01 – 2014-09-30: 20038000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2014-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 20038000 USD Concept: fundies:OperatingCashFlow Period: 2013-10-01 to 2014-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2014-09-30&surface=latest&period_type=duration&start=2013-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 20038000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#171761 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.	USD 11.3 million Exact value Exact value: 11298000 USD 2013-10-01 – 2014-09-30: 11298000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2014-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 11298000 USD Concept: fundies:CapitalExpenditure Period: 2013-10-01 to 2014-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2014-09-30&surface=latest&period_type=duration&start=2013-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 11298000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#184713 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.	USD 8.74 million Calculation and evidence 20038000 − 11298000 USD Exact free cash flow: 8740000 USD 2013-10-01 – 2014-09-30: 20038000 USD · Inspect Operating Cash Flow · Source 2013-10-01 – 2014-09-30: 11298000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2014-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 8740000 USD Concept: free-cash-flow Period: 2013-10-01 to 2014-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 20038000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#171761 Filing: 000105000716000015 Input fundies:CapitalExpenditure: 11298000 USD (2013-10-01 to 2014-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#184713 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.
2015 2014-10-01 – 2015-09-30	Unavailable Not reported for this period.	USD 25.05 million Exact value Exact value: 25046000 USD 2014-10-01 – 2015-09-30: 25046000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2015-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 25046000 USD Concept: fundies:OperatingCashFlow Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2015-09-30&surface=latest&period_type=duration&start=2014-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 25046000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#172012 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.	USD 8.56 million Exact value Exact value: 8557000 USD 2014-10-01 – 2015-09-30: 8557000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2015-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 8557000 USD Concept: fundies:CapitalExpenditure Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2015-09-30&surface=latest&period_type=duration&start=2014-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8557000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#184924 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.	USD 16.49 million Calculation and evidence 25046000 − 8557000 USD Exact free cash flow: 16489000 USD 2014-10-01 – 2015-09-30: 25046000 USD · Inspect Operating Cash Flow · Source 2014-10-01 – 2015-09-30: 8557000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2015-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 16489000 USD Concept: free-cash-flow Period: 2014-10-01 to 2015-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 25046000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#172012 Filing: 000105000716000015 Input fundies:CapitalExpenditure: 8557000 USD (2014-10-01 to 2015-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#184924 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.
2016 2015-10-01 – 2016-09-30	Unavailable Not reported for this period.	USD 32.78 million Exact value Exact value: 32777000 USD 2015-10-01 – 2016-09-30: 32777000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · NUTRACEUTICAL INTERNATIONAL CORP · 2016-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Operating Cash Flow: 32777000 USD Concept: fundies:OperatingCashFlow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3AOperatingCashFlow&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 32777000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#172263 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.	USD 8.95 million Exact value Exact value: 8950000 USD 2015-10-01 – 2016-09-30: 8950000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · NUTRACEUTICAL INTERNATIONAL CORP · 2016-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Capital Expenditure: 8950000 USD Concept: fundies:CapitalExpenditure Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007/explain?concept=fundies%3ACapitalExpenditure&period=2016-09-30&surface=latest&period_type=duration&start=2015-10-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8950000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#185134 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.	USD 23.83 million Calculation and evidence 32777000 − 8950000 USD Exact free cash flow: 23827000 USD 2015-10-01 – 2016-09-30: 32777000 USD · Inspect Operating Cash Flow · Source 2015-10-01 – 2016-09-30: 8950000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · NUTRACEUTICAL INTERNATIONAL CORP · 2016-09-30 NUTRACEUTICAL INTERNATIONAL CORP (edgar:1050007) Free cash flow: 23827000 USD Concept: free-cash-flow Period: 2015-10-01 to 2016-09-30 Values: Latest reported Published: 2026-11-02T05:33:31Z Snapshot: 35801a0e04c3fa94d6bb81ac78f45d4f0bb4e9eb4493931680698238f7fa5436 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1050007?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 32777000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#172263 Filing: 000105000716000015 Input fundies:CapitalExpenditure: 8950000 USD (2015-10-01 to 2016-09-30) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1050007/000105000716000015/nutr-20160930.xml#185134 Filing: 000105000716000015 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

128 filings · 2,316 latest values · 2,316 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001050007, 1050007, edgar:1050007

Also known as NUTRACEUTICAL INTERNATIONAL CORP

NUTRACEUTICAL INTERNATIONAL CORP

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Company performance

What changed year over year

Revenue

Operating cash flow

Capital expenditure

Where revenue goes

2016 2015-10-01 – 2016-09-30

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation